| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/02/2004 | US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene |
| 09/02/2004 | US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction |
| 09/02/2004 | US20040171642 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/02/2004 | US20040171640 Without opioid side effects; also treats migraines, diarrhea, urinary incontinence, pruritus, inflammatory reactions, allergies |
| 09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
| 09/02/2004 | US20040171612 Novel compounds with analgesic effect |
| 09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 09/02/2004 | DE20220955U1 Composition useful for treating e.g. depression, anxiety, obsessive-compulsive disorder, obesity comprises N-formyl paroxetine and a paroxetine compound |
| 09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | CA2515777A1 Biphenyl derivatives |
| 09/01/2004 | EP1452534A1 Pleuromutlin derivatives as antimicrobials |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1451148A2 2,w-diaminocarboxylic acid compounds |
| 09/01/2004 | EP1451147A1 Amino acid derivatives |
| 09/01/2004 | EP0942729B1 Use of nk-1 receptor antagonists for treating stress disorders |
| 09/01/2004 | CN1525975A Tert. alkylphenoxy substituted polycyclic compounds |
| 09/01/2004 | CN1525958A Method for the production of biperiden ii |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525953A Method for producing (meth) acrylic acid esters |
| 09/01/2004 | CN1524852A Novel compounds with analgesic effect |
| 09/01/2004 | CN1524851A Technology for industrialized production of hydrochloric acid multi-donepezil |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 08/31/2004 | US6784297 Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate |
| 08/31/2004 | US6784193 Mutilin derivatives and their use as antibacterials |
| 08/31/2004 | US6784186 Opiods which have less activity within the central nervous system, thus having fewer undesirable side-effects |
| 08/31/2004 | US6784182 Serine protease inhibitors |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/26/2004 | WO2004072036A1 Novel amlodipine cyclamate salt and a preparation method thereof |
| 08/26/2004 | WO2004072035A1 Graftable hindered amine light stabilizers |
| 08/26/2004 | WO2004072034A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071445A2 2-(aminomethyl)arylamide analgesics |
| 08/26/2004 | WO2004050610A3 Modulators of melanocortin receptor |
| 08/26/2004 | US20040167358 Method and reagents for N-alkylating ureides |
| 08/26/2004 | US20040167303 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 08/26/2004 | US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents |
| 08/26/2004 | US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 08/26/2004 | US20040167169 Antihistamines, antiallergens; bronchodilator |
| 08/26/2004 | US20040167168 Antihistamines; administering to humans, animals |
| 08/26/2004 | US20040167167 Biphenyl derivatives |
| 08/26/2004 | US20040167166 Amino-piperidine derivatives |
| 08/26/2004 | US20040167163 Optically pure paroxetine precursors |
| 08/26/2004 | US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/26/2004 | US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 08/26/2004 | US20040167119 2-(aminomethyl) arylamide analgesics |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040166137 Prevention membrane fusion, transmission of virus; respiratory syncytial virus |
| 08/26/2004 | DE10306503A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
| 08/26/2004 | DE10125567B4 Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted phenylurea derivatives, processes for their preparation and their use as medicaments |
| 08/26/2004 | CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | CA2515838A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | CA2515670A1 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | CA2513839A1 Graftable hindered amine light stabilizers |
| 08/25/2004 | EP1449830A1 Preparation of lactams from aliphatic - dinitriles |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448527A1 Method of resolving amlodipine racemate |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448520A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use |
| 08/25/2004 | EP1448200A2 (4-phenyl)piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/25/2004 | EP1448197A1 Amlodipine salt forms and processes for preparing them |
| 08/25/2004 | EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | EP1353750B1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 08/25/2004 | EP1278728B1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1163485C Amlodipine-series salt and preparing process and application thereof |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163224C Drugs for improving vesical excretory capacity |
| 08/24/2004 | US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 08/24/2004 | US6780891 Modulate opiate receptors; central nervous system disorders |
| 08/24/2004 | US6780876 Composition for keeping away vermin |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780863 Treat inflammatory and/or allergic conditions |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/24/2004 | US6780857 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/24/2004 | CA2065051C Improved use of .beta.2 bronchodilator drugs |
| 08/19/2004 | WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists |
| 08/19/2004 | WO2004069799A1 Method for the production of d-threo-2-phenyl-2-piperidine-2-yl acetates |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069794A2 New arylpiperazinyl compounds |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004058705A3 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 08/19/2004 | WO2004054973A3 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 08/19/2004 | WO2004048335A3 Mandelic acid derivatives |
| 08/19/2004 | WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/19/2004 | WO2003092688A3 Heterocyclic derivatives as opioid modulators |
| 08/19/2004 | WO2003032912A8 Treatment of cns disorders using cns target modulators |